Dose-escalation of filgrastim does not improve efficacy: Clinical tolerability and long-term follow-up on CALGB study 9141 adjuvant chemotherapy for node-positive breast cancer patients using dose-intensified doxorubicin plus cyclophosphamide followed by paclitaxel
2008 ◽
Vol 34
(3)
◽
pp. 223-230
◽
1998 ◽
Vol 42
(1)
◽
pp. 117-123
◽
1998 ◽
Vol 42
(1)
◽
pp. 252
2010 ◽
Keyword(s):
2010 ◽
Vol 210
(5)
◽
pp. 797-805.e1
◽
Keyword(s):
Keyword(s):
1997 ◽
Vol 38
(3)
◽
pp. 541-550
◽
Keyword(s):
Keyword(s):
2015 ◽